Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease
Olar P, Garg AX, Weir MA, Ahmadi F, McArthur E, Lam NN, Sontrop JM, Muanda FT. Pharmacol Res Perspect. 2024; 12(6):e70028.